Suggestions
David Pepperl
Principal Nonclinical Consultant at Biologics Consulting
David J. Pepperl, PhD, is a Principal Consultant at Biologics Consulting, where he specializes in pharmacology and toxicology, particularly in the early-stage development of biologic products. He has a robust background in nonclinical development, having previously worked as a toxicologist and preclinical development scientist at TherImmune Research Corporation. In this role, he was responsible for drafting nonclinical development plans and managing preclinical programs for various clients.1
Education and Experience
- PhD in Pharmacology & Toxicology: University of Arizona (1994)
- Postdoctoral Work: Conducted at Pharmacia and Parke-Davis Pharmaceuticals, as well as Harvard University and Yale University.1
- BS in Biochemistry: Michigan State University (1988)
Role at Biologics Consulting
At Biologics Consulting, Dr. Pepperl has been instrumental since joining as a Senior Consultant in 2004. He leads the Nonclinical group and has designed numerous nonclinical development programs for a variety of biologic products, including:
- Cell and gene therapies
- mRNA therapies
- Vaccines
- Monoclonal antibodies
His responsibilities also include performing nonclinical safety assessments, authoring regulatory submission sections (such as pre-INDs and INDs), and assisting clients with interactions with regulatory agencies like the FDA.12
Professional Affiliations
Dr. Pepperl is actively involved in the American College of Toxicology (ACT), serving on its Program Committee from 2017 to 2020 and currently on the communications committee.3
Current Location
He resides in Montgomery Village, Maryland, with his family.1
